Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 09, 2021

SELL
$69.38 - $86.75 $856,773 - $1.07 Million
-12,349 Closed
0 $0
Q1 2021

Apr 30, 2021

SELL
$72.25 - $168.95 $15,750 - $36,831
-218 Reduced 1.73%
12,349 $920,000
Q4 2020

Feb 02, 2021

SELL
$125.56 - $178.74 $35,407 - $50,404
-282 Reduced 2.19%
12,567 $2.14 Million
Q3 2020

Nov 10, 2020

BUY
$127.12 - $172.34 $128,264 - $173,891
1,009 Added 8.52%
12,849 $1.8 Million
Q2 2020

Aug 12, 2020

BUY
$93.0 - $171.7 $342,519 - $632,371
3,683 Added 45.15%
11,840 $1.9 Million
Q1 2020

May 13, 2020

SELL
$82.38 - $131.64 $771,076 - $1.23 Million
-9,360 Reduced 53.43%
8,157 $798,000
Q4 2019

Feb 12, 2020

BUY
$76.53 - $135.58 $564,026 - $999,224
7,370 Added 72.63%
17,517 $2.26 Million
Q3 2019

Nov 14, 2019

BUY
$72.81 - $156.91 $738,803 - $1.59 Million
10,147 New
10,147 $764,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track British Columbia Investment Management Corp Portfolio

Follow British Columbia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.